{"resourceType":"StructureDefinition","id":"MedicinalProductPharmaceutical.routeOfAdministration.maxTreatmen","meta":{"lastUpdated":"2021-01-17T07:06:13.533+11:00"},"url":"http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical.routeOfAdministration.maxTreatmen","version":"4.0.1","name":"MedicinalProductPharmaceutical.routeOfAdministration.maxTreatmentPeriod","title":"MedicinalProductPharmaceutical.routeOfAdministration.maxTreatmentPeriod","status":"draft","experimental":true,"date":"2021-01-17T07:06:13+11:00","publisher":"HL7 FHIR Standard","contact":[{"telecom":[{"system":"url","value":"http://hl7.org/fhir"}]}],"description":"Data Element for MedicinalProductPharmaceutical.routeOfAdministration.maxTreatmentPeriod","purpose":"Data Elements are defined for each element to assist in questionnaire construction etc","fhirVersion":"4.0.1","mapping":[{"identity":"w5","uri":"http://hl7.org/fhir/fivews","name":"FiveWs Pattern Mapping"},{"identity":"rim","uri":"http://hl7.org/v3","name":"RIM Mapping"}],"kind":"logical","abstract":false,"type":"MedicinalProductPharmaceutical.routeOfAdministration.maxTreatmentPeriod","baseDefinition":"http://hl7.org/fhir/StructureDefinition/Element","derivation":"specialization","snapshot":{"element":[{"id":"MedicinalProductPharmaceutical.routeOfAdministration.maxTreatmentPeriod","path":"MedicinalProductPharmaceutical.routeOfAdministration.maxTreatmentPeriod","short":"The maximum treatment period during which an Investigational Medicinal Product can be administered as per the protocol referenced in the clinical trial authorisation","definition":"The maximum treatment period during which an Investigational Medicinal Product can be administered as per the protocol referenced in the clinical trial authorisation.","min":0,"max":"1","base":{"path":"MedicinalProductPharmaceutical.routeOfAdministration.maxTreatmentPeriod","min":0,"max":"1"},"type":[{"code":"Duration"}],"isModifier":false,"isSummary":true}]}}